Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4

Eye

Volumn 25, Issue 11, 2011, Pages 1447-1456

  Muqit, M M K ^a,b   Marcellino, G R ^c   Henson, D B ^a,b   Young, L B ^a   Turner, G S ^a   Stanga, P E ^a,b  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c OptiMedica Corporation   (United States)

Author keywords

laser dosimetry; Pascal panretinal photocoagulation; proliferative diabetic retinopathy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE SEVERITY; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; LASER COAGULATION; MALE; PANRETINAL LASER PHOTOCOAGULATION; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS HEMORRHAGE;

EID: 80955136446     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.188     Document Type: Article

References (22)

1. Diabetic Retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy. The second report of Diabetic Retinopathy Study findings. Ophthalmology 1978; 85: 82-106.
2. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study findings, DRS report number 8. Ophthalmology. 1981; 88, 533-600.
3. Little HL. Treatment of proliferative diabetic retinopathy. Long-term results of argon laser photocoagulation. Ophthalmology 1985; 92(2): 279-283. (Pubitemid 15137772)
4. Kaiser RS, Maguire MG, Grunwald JE, Lieb D, Jani B, Brucker AJ et al. One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy. Am J Ophthalmol 2000; 129(2): 178-185. (Pubitemid 30089277)
5. Reddy VM, Zamora RL, Olk RJ. Quantification of retinal ablation in proliferative diabetic retinopathy. Am J Ophthalmol 1995; 119(6): 760-766.
6. Bailey CC, Sparrow JM, Grey RHB, Cheng H. The national diabetic retinopathy laser treatment audit. II. Proliferative retinopathy. Eye (Lond) 1998; 12(1): 77-84. (Pubitemid 28130068)
7. Bailey CC, Sparrow JM, Grey RHB, Cheng H. The national diabetic retinopathy laser treatment audit. III. Clinical outcomes. Eye (Lond) 1999; 13: 151-159. (Pubitemid 29210131)
8. Diabetic Retinopathy Clinical Research Network. Brucker AJ, Qin H, Elman MJ, Glassman AR, Gross JG, Kollman C et al. Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Arch Ophthalmol 2009; 127(2): 132-140.
9. Muqit MMK, Sanghvi C, McLauchlan R, Delgado C, Young LB, Charles SJ et al. Study of clinical applications and safety for Pascal ((R)) laser photocoagulation in retinal vascular disorders. Acta Ophthalmol 2010; e-pub ahead of print 16 February 2010; doi:10.1111/j. 1 755-37 68. 2 009.01854.x.
10. Muqit MMK, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ et al. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy. Arch Ophthalmol 2010; 128(5): 525-533
11. Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group. Arch Ophthalmol 1979; 97: 654-655.
12. Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Patton N et al. In vivo laser-tissue interactions and healing responses from 20-vs 100-millisecond pulse Pascal photocoagulation burns. Arch Ophthalmol 2010; 128(4): 448-455.
13. Muqit MM, Denniss J, Nourrit V, Marcellino GR, Henson DB, Schiessl I et al. Spatial and spectral imaging of retinal laser photocoagulation burns. Invest Ophthalmol Vis Sci 2011; 52(2): 994-1002.
14. Kaufman SC, Ferris III FL, Seigel DG, Davis MD, DeMets DL. Factors associated with visual outcome after photocoagulation for diabetic retinopathy. Diabetic Retinopathy Study Report No. 13. Invest Ophthalmol Vis Sci 1989; 30(1): 23-28. (Pubitemid 19039875)
15. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmology 1981; 88(7): 583-600.
16. Doft BH, Metz DJ, Kelsey SF. Augmentation laser for proliferative diabetic retinopathy that fails to respond to initial panretinal photocoagulation. Ophthalmology 1992; 99(11): 1728-1734; discussion 1734-1735.
17. Barr CC. Estimation of the maximum number of argon laser burns possible in panretinal photocoagulation. Am J Ophthalmol 1984; 97(6): 697-703. (Pubitemid 14082955)
18. Taylor E, Jennings A. Calculation of total retinal area. Br J Ophthalmol 1971; 55(4): 262-265.
19. Drasdo N, Fowler CW. Non-linear projection of the retinal image in a wide-angle schematic eye. Br J Ophthalmol 1974; 58(8): 709-714.
20. Aylward GW, Pearson RV, Jagger JD, Hamilton AM. Extensive argon laser photocoagulation in the treatment of proliferative diabetic retinopathy. Br J Ophthalmol 1989; 73(3): 197-201 (Pubitemid 19094405)
21. Royal College of Ophthalmologists. Guidelines for Diabetic Retinopathy. RCOphth: London, 2005, pp 54-61.
22. Al-Hussainy S, Dodson PM, Gibson JM. Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times. Eye (Lond) 2008; 22(1): 96-99